KLRK1 and neoplasm: Several activating receptors, including NKG2D and activating killer immunoglobulin-like receptors (KIRs), are capable of recognizing their corresponding interactive ‘induced-self’ ligands that either lack or express merely on healthy cells but highly express on cancer cells in response to the activation of tumor-associated pathways (11, 12).